The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

Benchmark NSE Nifty50 index ended up 375.16 points at 25790.95, while the BSE Sensex stood up 1359.51 points at 84544.31.

Mumbai: Sun Pharmaceutical Industries Ltd. has appointed Tejash Chheda as the General Manager - Head of Media. Chheda shared ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 rose 1.03% to 1,865.50 Indian rupees Friday, on what proved to be an ...

Welcome to the Sun Pharmaceutical Industries Stock Liveblog, your ultimate source for real-time updates and analysis of one ...

Tejash Chheda joins Sun Pharma as general manager, head of media at Sun Pharma. Prior to this role, was working with Reckitt ...

Tejash Chheda has been appointed as the General Manager, Head of Media at Sun Pharma. He took to LinkedIn to announce his new ...

Welcome to the Sun Pharmaceutical Industries Stock Liveblog, your ultimate source for real-time updates and analysis of one ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.16% to 1,865.90 Indian rupees Tuesday, on what proved to be an ...

Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to their offspring doesn’t ...